Welcome to our dedicated page for Sabra Health Care Reit SEC filings (Ticker: SBRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sabra Health Care REIT, Inc. filings document the reporting obligations of a Nasdaq-listed healthcare REIT that owns and invests in healthcare real estate through subsidiaries. Its 8-K reports cover operating results, supplemental information packages, non-GAAP financial measure reconciliations, Regulation FD materials, capital-structure events and material definitive agreements.
Proxy materials describe board and shareholder governance for the Maryland corporation. Other disclosures address common stock listed under the SBRA symbol, equity distribution arrangements, debt redemption notices, related financing arrangements and risk or governance matters tied to the company’s REIT structure and healthcare real estate portfolio.
Insider Trading Alert: Michael J. Foster, Director of Sabra Healthcare REIT (SBRA), reported a gift transaction of 750 shares of Common Stock on June 26, 2025, at $0 per share. Following the transaction, Foster's direct ownership stands at 73,067 shares, which includes 8,178 unvested stock units and 43,619 vested but deferred stock units.
Additionally, Foster maintains indirect ownership of 42,411.745 shares through a 401(k) Plan. The total beneficial ownership combines both direct and indirect holdings, demonstrating significant insider stake in the company.
Key Details:
- Transaction Code: G (Gift)
- Direct Holdings: 73,067 shares (including stock units)
- Indirect Holdings: 42,411.745 shares via 401(k)
- Filing Date: June 28, 2025
- Transaction Date: June 26, 2025